Anirban Maitra, Professor of Pathology and Medicine at NYU Langone Health, shared a post on X about a paper by Feng Wang et al. published in Cancer Cell:
“Striking cover of Cancer Cell showcasing the dramatic meeting of the Tao River and the Yellow River in Gansu Province, China. The cover signifies the efficacy of combining aPD-1 and aCTLA-4 in patients with locally advanced MSI-H/dMMR.”
Title: Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study
Authors: Feng Wang, Gong Chen, Meng Qiu, Jinfeng Ma, Xianwei Mo, Haiyi Liu, Yongqiang Li, Peirong Ding, Xiangbin Wan, Yingbin Hu, Xiwen Huang, Weiqin Jiang, Xiaojun Wu, Jia Luo, Yanbing Zhou, Leping Li, Yanlai Sun, Quan Wang, Nanya Wang, Wu Jiang, Weitang Yuan, Liren Li, Linlin Liu, Xianglin Yuan, Guihua Wang, Zhangfa Song, Heli Liu, Jie Ge, Yaxu Wang, Peng Zhao, Taiyuan Li, Jun You, Jianqiang Tang, Xiaobo Du, Junzhong Lin, Rongxin Zhang, Zan Fu, Jianmin Xu, Haijun Zhong, Liang Kang, Yanhong Deng, Xiaoxiao Lu, Qun Guo, Hui Zhou, and Rui-Hua Xu.
You can read the Full Article in Cancer Cell.
More posts featuring Anirban Maitra.
